| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/20/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 07/05/2023 | 316.67% | HC Wainwright & Co. | $2 → $4 | Reiterates | Buy → Buy |
| 02/15/2023 | 108.33% | HC Wainwright & Co. | → $2 | Reiterates | → Buy |
| 07/15/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 07/15/2022 | 108.33% | HC Wainwright & Co. | $6 → $2 | Maintains | Buy |
| 03/07/2022 | 420.83% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 11/23/2021 | 525% | HC Wainwright & Co. | → $6 | Initiates Coverage On | → Buy |
| 07/01/2021 | 629.17% | Northland Capital Markets | → $7 | Initiates Coverage On | → Outperform |
What is the target price for Biotricity (BTCY)?
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on November 20, 2023. The analyst firm set a price target for $0.00 expecting BTCY to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biotricity (BTCY)?
The latest analyst rating for Biotricity (NASDAQ: BTCY) was provided by HC Wainwright & Co., and Biotricity downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Biotricity (BTCY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on November 20, 2023 so you should expect the next rating to be made available sometime around November 20, 2024.
Is the Analyst Rating Biotricity (BTCY) correct?
While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a downgraded with a price target of $0.00 to $0.00. The current price Biotricity (BTCY) is trading at is $0.96, which is out of the analyst's predicted range.